Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer

Published on 2 Jun 2022 on Investor's Business Daily

On today's stock market, however, Regeneron stock toppled 4.3% to 630.70. Shares of Sanofi stock...

Read the rest of the article

Start tracking your investments with Statfolio

Novavax received an upfront payment of $500 million and up to $700 million in additional...

Investor's Business Daily 21 Nov 2024

Ariel Investments, an investment management company, released its “Ariel Global Fund” third-quart...

Insider Monkey · via Yahoo Finance 20 Nov 2024

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are goin...

Insider Monkey · via Yahoo Finance 20 Nov 2024

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we ...

Insider Monkey · via Yahoo Finance 20 Nov 2024

The FDA had issued a complete response letter (CRL) for the first sBLA seeking approval of Dupixe...

Zacks · via Yahoo Finance 18 Nov 2024

Its stock in the US tumbled almost five percent. GSK saw their shares go down almost four percent...

The Independent · via Yahoo Finance 15 Nov 2024

Companies that make immunizations bore the brunt of the losses, with France’s Sanofi SA - a maker...

The Boston Globe 15 Nov 2024

Have a confidential tip for our reporters? Pharmaceutical stocks declined as President-elect Dona...

Bloomberg 15 Nov 2024

Have a confidential tip for our reporters? European stocks fell as traders pared back expectation...

Bloomberg 15 Nov 2024

(Bloomberg) -- Health stocks slumped on Friday as Wall Street weighed the impact that prominent...

Bloomberg · via Yahoo Finance 15 Nov 2024